A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit ...

Ahead of the study's publication, the data was shared at the 2026 European Society for Medical Oncology Gastrointestinal ...

Patients with metastatic colorectal cancer that had stopped responding to at least two prior treatment regimens gained ...

Real-world comparative outcomes of chemo-immunotherapy versus chemotherapy in colon cancer: A multi-center retrospective cohort study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Colorectal cancer is one of the most prevalent tumors and a leading cause of cancer-related mortality. Despite advances achieved in recent years, resistance to available treatments remains one of the ...

It's stage III and contained.

Colon cancer diagnosis involves colonoscopy, imaging, and blood tests, with staging guiding treatment decisions. Stage 1 treatment typically involves surgery, while stage 2 may include chemotherapy ...

The timing of adjuvant chemotherapy following curative resection of colorectal cancer has emerged as a critical determinant of long-term outcomes. Prompt initiation aims to eradicate microscopic ...

It wasn't his first bout with cancer. Spencer Laird knew he had to try something new. When 30-year-old diesel mechanic Spencer Laird learned he had cancer, the diagnosis was all too familiar. At 27, ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have ...

The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...